Stallion India Fluorochemicals Presents Investor Update Highlighting Growth Initiatives and Financial Performance
Stallion India Fluorochemicals shared an investor presentation for the quarter ended December 31, 2025. The company received Environmental Clearance for a 10,000 MT R-32 manufacturing facility in Bhilwara, Rajasthan, expected to commence production by August 2026. This facility aims for ₹250 crore topline in FY26-27 and ₹500-600 crore in FY27-28. The company projects a 30-35% CAGR for the next three years.
The environmental clearance for a major R-32 manufacturing facility and projected topline growth figures are material developments that are expected to significantly impact the company's future revenue and profitability.
The announcement details significant expansion plans, receipt of crucial environmental clearance for a new manufacturing facility, and positive financial projections, indicating a strong growth outlook.
Stallion India Fluorochemicals Limited has released an investor presentation detailing its financial results for the quarter and nine months ended December 31, 2025. The presentation outlines the company's strategic vision, including expansion plans for its pan-India distribution network with two new facilities underway. The company is advancing specialty and semiconductor gas capabilities at its Khalapur facility, investing in a liquid helium processing capacity of 1,200 metric tons per annum.
Furthermore, Stallion India Fluorochemicals has received Environmental Clearance from SEIAA, Rajasthan, for a proposed 10,000 MT R-32 manufacturing facility at Bhilwara. Construction for this facility has commenced, with an expected commissioning in August 2026. This project is anticipated to generate ₹250 crore in topline in FY26-27 and ₹500-600 crore in FY27-28, with an expected PAT margin of 22-24%. The company expects these initiatives to improve profit margins by 3-4% and is confident in its ambition to become an industry leader.
The presentation also provides an overview of the company's business, core metrics, and key milestones. It highlights the company's diversified customer base, strategic locational presence with four operational facilities and upcoming expansions in Mambattu, Andhra Pradesh, and potentially in Eastern India. The company is focusing on innovative product portfolios, including liquid helium supply for advanced applications and environmentally responsible HFOs. Financially, the company projects a 30-35% CAGR for the next three years, with plans for backward integration and higher value products to enhance profitability.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.